Elite Pharmaceuticals Financial Overview
Elite Pharmaceuticals's market cap is currently $537.14M. The company's EPS TTM is $0.005; its P/E ratio is 89.11; Elite Pharmaceuticals is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
